 | • レポートコード：QFJ1-3992 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、118ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査レポートでは、細胞ベース免疫療法の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（自己細胞免疫療法、CAR（キメラ抗原受容体）T細胞療法、樹状細胞ベースワクチン療法）、用途別市場規模（病院、診療所、外来外科センター、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・細胞ベース免疫療法の市場動向 ・企業の競争状況、市場シェア ・細胞ベース免疫療法の種類別市場規模と予測2016-2027（自己細胞免疫療法、CAR（キメラ抗原受容体）T細胞療法、樹状細胞ベースワクチン療法） ・細胞ベース免疫療法の用途別市場規模と予測2016-2027（病院、診療所、外来外科センター、その他） ・細胞ベース免疫療法の北米市場規模2016-2027（アメリカ、カナダ） ・細胞ベース免疫療法の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・細胞ベース免疫療法のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・細胞ベース免疫療法の中南米市場規模2016-2027（メキシコ、ブラジル） ・細胞ベース免疫療法の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Novartis、Gilead Sciences、AbbVie、Bristol-Myers Squibb、Amgen、AstraZeneca、Biogen、Boehringer Ingelheim、Eli Lilly and Company、GSK、Pfizer、Roche、Takara Bio、Bausch Health、Apac Biotech、Dendreon Pharmaceuticals (SanPower)、JW CreaGene、Green Cross Corp） ・結論 |
Market Analysis and Insights: Global Cell-Based Immunotherapy Market
The global Cell-Based Immunotherapy market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Cell-Based Immunotherapy market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Cell-Based Immunotherapy market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Cell-Based Immunotherapy market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Cell-Based Immunotherapy market.
Global Cell-Based Immunotherapy Scope and Market Size
Cell-Based Immunotherapy market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Cell-Based Immunotherapy market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Autologous Cellular Immunotherapy
Chimeric Antigen Receptor (CAR) T-Cell Therapy
Dendritic Cell-based Vaccine Therapy
Segment by Application
Hospitals
Clinics
Ambulatory Surgical Centers
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Novartis
Gilead Sciences
AbbVie
Bristol-Myers Squibb
Amgen
AstraZeneca
Biogen
Boehringer Ingelheim
Eli Lilly and Company
GSK
Pfizer
Roche
Takara Bio
Bausch Health
Apac Biotech
Dendreon Pharmaceuticals (SanPower)
JW CreaGene
Green Cross Corp
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cell-Based Immunotherapy Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Autologous Cellular Immunotherapy
1.2.3 Chimeric Antigen Receptor (CAR) T-Cell Therapy
1.2.4 Dendritic Cell-based Vaccine Therapy
1.3 Market by Application
1.3.1 Global Cell-Based Immunotherapy Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Ambulatory Surgical Centers
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Cell-Based Immunotherapy Market Perspective (2016-2027)
2.2 Cell-Based Immunotherapy Growth Trends by Regions
2.2.1 Cell-Based Immunotherapy Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Cell-Based Immunotherapy Historic Market Share by Regions (2016-2021)
2.2.3 Cell-Based Immunotherapy Forecasted Market Size by Regions (2022-2027)
2.3 Cell-Based Immunotherapy Industry Dynamic
2.3.1 Cell-Based Immunotherapy Market Trends
2.3.2 Cell-Based Immunotherapy Market Drivers
2.3.3 Cell-Based Immunotherapy Market Challenges
2.3.4 Cell-Based Immunotherapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cell-Based Immunotherapy Players by Revenue
3.1.1 Global Top Cell-Based Immunotherapy Players by Revenue (2016-2021)
3.1.2 Global Cell-Based Immunotherapy Revenue Market Share by Players (2016-2021)
3.2 Global Cell-Based Immunotherapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Cell-Based Immunotherapy Revenue
3.4 Global Cell-Based Immunotherapy Market Concentration Ratio
3.4.1 Global Cell-Based Immunotherapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cell-Based Immunotherapy Revenue in 2020
3.5 Cell-Based Immunotherapy Key Players Head office and Area Served
3.6 Key Players Cell-Based Immunotherapy Product Solution and Service
3.7 Date of Enter into Cell-Based Immunotherapy Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Cell-Based Immunotherapy Breakdown Data by Type
4.1 Global Cell-Based Immunotherapy Historic Market Size by Type (2016-2021)
4.2 Global Cell-Based Immunotherapy Forecasted Market Size by Type (2022-2027)
5 Cell-Based Immunotherapy Breakdown Data by Application
5.1 Global Cell-Based Immunotherapy Historic Market Size by Application (2016-2021)
5.2 Global Cell-Based Immunotherapy Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Cell-Based Immunotherapy Market Size (2016-2027)
6.2 North America Cell-Based Immunotherapy Market Size by Type
6.2.1 North America Cell-Based Immunotherapy Market Size by Type (2016-2021)
6.2.2 North America Cell-Based Immunotherapy Market Size by Type (2022-2027)
6.2.3 North America Cell-Based Immunotherapy Market Size by Type (2016-2027)
6.3 North America Cell-Based Immunotherapy Market Size by Application
6.3.1 North America Cell-Based Immunotherapy Market Size by Application (2016-2021)
6.3.2 North America Cell-Based Immunotherapy Market Size by Application (2022-2027)
6.3.3 North America Cell-Based Immunotherapy Market Size by Application (2016-2027)
6.4 North America Cell-Based Immunotherapy Market Size by Country
6.4.1 North America Cell-Based Immunotherapy Market Size by Country (2016-2021)
6.4.2 North America Cell-Based Immunotherapy Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Cell-Based Immunotherapy Market Size (2016-2027)
7.2 Europe Cell-Based Immunotherapy Market Size by Type
7.2.1 Europe Cell-Based Immunotherapy Market Size by Type (2016-2021)
7.2.2 Europe Cell-Based Immunotherapy Market Size by Type (2022-2027)
7.2.3 Europe Cell-Based Immunotherapy Market Size by Type (2016-2027)
7.3 Europe Cell-Based Immunotherapy Market Size by Application
7.3.1 Europe Cell-Based Immunotherapy Market Size by Application (2016-2021)
7.3.2 Europe Cell-Based Immunotherapy Market Size by Application (2022-2027)
7.3.3 Europe Cell-Based Immunotherapy Market Size by Application (2016-2027)
7.4 Europe Cell-Based Immunotherapy Market Size by Country
7.4.1 Europe Cell-Based Immunotherapy Market Size by Country (2016-2021)
7.4.2 Europe Cell-Based Immunotherapy Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Cell-Based Immunotherapy Market Size (2016-2027)
8.2 Asia-Pacific Cell-Based Immunotherapy Market Size by Type
8.2.1 Asia-Pacific Cell-Based Immunotherapy Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Cell-Based Immunotherapy Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Cell-Based Immunotherapy Market Size by Type (2016-2027)
8.3 Asia-Pacific Cell-Based Immunotherapy Market Size by Application
8.3.1 Asia-Pacific Cell-Based Immunotherapy Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Cell-Based Immunotherapy Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Cell-Based Immunotherapy Market Size by Application (2016-2027)
8.4 Asia-Pacific Cell-Based Immunotherapy Market Size by Region
8.4.1 Asia-Pacific Cell-Based Immunotherapy Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Cell-Based Immunotherapy Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Cell-Based Immunotherapy Market Size (2016-2027)
9.2 Latin America Cell-Based Immunotherapy Market Size by Type
9.2.1 Latin America Cell-Based Immunotherapy Market Size by Type (2016-2021)
9.2.2 Latin America Cell-Based Immunotherapy Market Size by Type (2022-2027)
9.2.3 Latin America Cell-Based Immunotherapy Market Size by Type (2016-2027)
9.3 Latin America Cell-Based Immunotherapy Market Size by Application
9.3.1 Latin America Cell-Based Immunotherapy Market Size by Application (2016-2021)
9.3.2 Latin America Cell-Based Immunotherapy Market Size by Application (2022-2027)
9.3.3 Latin America Cell-Based Immunotherapy Market Size by Application (2016-2027)
9.4 Latin America Cell-Based Immunotherapy Market Size by Country
9.4.1 Latin America Cell-Based Immunotherapy Market Size by Country (2016-2021)
9.4.2 Latin America Cell-Based Immunotherapy Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cell-Based Immunotherapy Market Size (2016-2027)
10.2 Middle East & Africa Cell-Based Immunotherapy Market Size by Type
10.2.1 Middle East & Africa Cell-Based Immunotherapy Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Cell-Based Immunotherapy Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Cell-Based Immunotherapy Market Size by Type (2016-2027)
10.3 Middle East & Africa Cell-Based Immunotherapy Market Size by Application
10.3.1 Middle East & Africa Cell-Based Immunotherapy Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Cell-Based Immunotherapy Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Cell-Based Immunotherapy Market Size by Application (2016-2027)
10.4 Middle East & Africa Cell-Based Immunotherapy Market Size by Country
10.4.1 Middle East & Africa Cell-Based Immunotherapy Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Cell-Based Immunotherapy Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Novartis
11.1.1 Novartis Company Details
11.1.2 Novartis Business Overview
11.1.3 Novartis Cell-Based Immunotherapy Introduction
11.1.4 Novartis Revenue in Cell-Based Immunotherapy Business (2016-2021)
11.1.5 Novartis Recent Development
11.2 Gilead Sciences
11.2.1 Gilead Sciences Company Details
11.2.2 Gilead Sciences Business Overview
11.2.3 Gilead Sciences Cell-Based Immunotherapy Introduction
11.2.4 Gilead Sciences Revenue in Cell-Based Immunotherapy Business (2016-2021)
11.2.5 Gilead Sciences Recent Development
11.3 AbbVie
11.3.1 AbbVie Company Details
11.3.2 AbbVie Business Overview
11.3.3 AbbVie Cell-Based Immunotherapy Introduction
11.3.4 AbbVie Revenue in Cell-Based Immunotherapy Business (2016-2021)
11.3.5 AbbVie Recent Development
11.4 Bristol-Myers Squibb
11.4.1 Bristol-Myers Squibb Company Details
11.4.2 Bristol-Myers Squibb Business Overview
11.4.3 Bristol-Myers Squibb Cell-Based Immunotherapy Introduction
11.4.4 Bristol-Myers Squibb Revenue in Cell-Based Immunotherapy Business (2016-2021)
11.4.5 Bristol-Myers Squibb Recent Development
11.5 Amgen
11.5.1 Amgen Company Details
11.5.2 Amgen Business Overview
11.5.3 Amgen Cell-Based Immunotherapy Introduction
11.5.4 Amgen Revenue in Cell-Based Immunotherapy Business (2016-2021)
11.5.5 Amgen Recent Development
11.6 AstraZeneca
11.6.1 AstraZeneca Company Details
11.6.2 AstraZeneca Business Overview
11.6.3 AstraZeneca Cell-Based Immunotherapy Introduction
11.6.4 AstraZeneca Revenue in Cell-Based Immunotherapy Business (2016-2021)
11.6.5 AstraZeneca Recent Development
11.7 Biogen
11.7.1 Biogen Company Details
11.7.2 Biogen Business Overview
11.7.3 Biogen Cell-Based Immunotherapy Introduction
11.7.4 Biogen Revenue in Cell-Based Immunotherapy Business (2016-2021)
11.7.5 Biogen Recent Development
11.8 Boehringer Ingelheim
11.8.1 Boehringer Ingelheim Company Details
11.8.2 Boehringer Ingelheim Business Overview
11.8.3 Boehringer Ingelheim Cell-Based Immunotherapy Introduction
11.8.4 Boehringer Ingelheim Revenue in Cell-Based Immunotherapy Business (2016-2021)
11.8.5 Boehringer Ingelheim Recent Development
11.9 Eli Lilly and Company
11.9.1 Eli Lilly and Company Company Details
11.9.2 Eli Lilly and Company Business Overview
11.9.3 Eli Lilly and Company Cell-Based Immunotherapy Introduction
11.9.4 Eli Lilly and Company Revenue in Cell-Based Immunotherapy Business (2016-2021)
11.9.5 Eli Lilly and Company Recent Development
11.10 GSK
11.10.1 GSK Company Details
11.10.2 GSK Business Overview
11.10.3 GSK Cell-Based Immunotherapy Introduction
11.10.4 GSK Revenue in Cell-Based Immunotherapy Business (2016-2021)
11.10.5 GSK Recent Development
11.11 Pfizer
11.11.1 Pfizer Company Details
11.11.2 Pfizer Business Overview
11.11.3 Pfizer Cell-Based Immunotherapy Introduction
11.11.4 Pfizer Revenue in Cell-Based Immunotherapy Business (2016-2021)
11.11.5 Pfizer Recent Development
11.12 Roche
11.12.1 Roche Company Details
11.12.2 Roche Business Overview
11.12.3 Roche Cell-Based Immunotherapy Introduction
11.12.4 Roche Revenue in Cell-Based Immunotherapy Business (2016-2021)
11.12.5 Roche Recent Development
11.13 Takara Bio
11.13.1 Takara Bio Company Details
11.13.2 Takara Bio Business Overview
11.13.3 Takara Bio Cell-Based Immunotherapy Introduction
11.13.4 Takara Bio Revenue in Cell-Based Immunotherapy Business (2016-2021)
11.13.5 Takara Bio Recent Development
11.14 Bausch Health
11.14.1 Bausch Health Company Details
11.14.2 Bausch Health Business Overview
11.14.3 Bausch Health Cell-Based Immunotherapy Introduction
11.14.4 Bausch Health Revenue in Cell-Based Immunotherapy Business (2016-2021)
11.14.5 Bausch Health Recent Development
11.15 Apac Biotech
11.15.1 Apac Biotech Company Details
11.15.2 Apac Biotech Business Overview
11.15.3 Apac Biotech Cell-Based Immunotherapy Introduction
11.15.4 Apac Biotech Revenue in Cell-Based Immunotherapy Business (2016-2021)
11.15.5 Apac Biotech Recent Development
11.16 Dendreon Pharmaceuticals (SanPower)
11.16.1 Dendreon Pharmaceuticals (SanPower) Company Details
11.16.2 Dendreon Pharmaceuticals (SanPower) Business Overview
11.16.3 Dendreon Pharmaceuticals (SanPower) Cell-Based Immunotherapy Introduction
11.16.4 Dendreon Pharmaceuticals (SanPower) Revenue in Cell-Based Immunotherapy Business (2016-2021)
11.16.5 Dendreon Pharmaceuticals (SanPower) Recent Development
11.17 JW CreaGene
11.17.1 JW CreaGene Company Details
11.17.2 JW CreaGene Business Overview
11.17.3 JW CreaGene Cell-Based Immunotherapy Introduction
11.17.4 JW CreaGene Revenue in Cell-Based Immunotherapy Business (2016-2021)
11.17.5 JW CreaGene Recent Development
11.18 Green Cross Corp
11.18.1 Green Cross Corp Company Details
11.18.2 Green Cross Corp Business Overview
11.18.3 Green Cross Corp Cell-Based Immunotherapy Introduction
11.18.4 Green Cross Corp Revenue in Cell-Based Immunotherapy Business (2016-2021)
11.18.5 Green Cross Corp Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Cell-Based Immunotherapy Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Autologous Cellular Immunotherapy
Table 3. Key Players of Chimeric Antigen Receptor (CAR) T-Cell Therapy
Table 4. Key Players of Dendritic Cell-based Vaccine Therapy
Table 5. Global Cell-Based Immunotherapy Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Cell-Based Immunotherapy Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Cell-Based Immunotherapy Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Cell-Based Immunotherapy Market Share by Regions (2016-2021)
Table 9. Global Cell-Based Immunotherapy Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Cell-Based Immunotherapy Market Share by Regions (2022-2027)
Table 11. Cell-Based Immunotherapy Market Trends
Table 12. Cell-Based Immunotherapy Market Drivers
Table 13. Cell-Based Immunotherapy Market Challenges
Table 14. Cell-Based Immunotherapy Market Restraints
Table 15. Global Cell-Based Immunotherapy Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Cell-Based Immunotherapy Market Share by Players (2016-2021)
Table 17. Global Top Cell-Based Immunotherapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cell-Based Immunotherapy as of 2020)
Table 18. Ranking of Global Top Cell-Based Immunotherapy Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Cell-Based Immunotherapy Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Cell-Based Immunotherapy Product Solution and Service
Table 22. Date of Enter into Cell-Based Immunotherapy Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Cell-Based Immunotherapy Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Cell-Based Immunotherapy Revenue Market Share by Type (2016-2021)
Table 26. Global Cell-Based Immunotherapy Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Cell-Based Immunotherapy Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Cell-Based Immunotherapy Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Cell-Based Immunotherapy Revenue Market Share by Application (2016-2021)
Table 30. Global Cell-Based Immunotherapy Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Cell-Based Immunotherapy Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Cell-Based Immunotherapy Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Cell-Based Immunotherapy Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Cell-Based Immunotherapy Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Cell-Based Immunotherapy Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Cell-Based Immunotherapy Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Cell-Based Immunotherapy Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Cell-Based Immunotherapy Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Cell-Based Immunotherapy Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Cell-Based Immunotherapy Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Cell-Based Immunotherapy Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Cell-Based Immunotherapy Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Cell-Based Immunotherapy Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Cell-Based Immunotherapy Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Cell-Based Immunotherapy Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Cell-Based Immunotherapy Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Cell-Based Immunotherapy Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Cell-Based Immunotherapy Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Cell-Based Immunotherapy Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Cell-Based Immunotherapy Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Cell-Based Immunotherapy Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Cell-Based Immunotherapy Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Cell-Based Immunotherapy Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Cell-Based Immunotherapy Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Cell-Based Immunotherapy Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Cell-Based Immunotherapy Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Cell-Based Immunotherapy Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Cell-Based Immunotherapy Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Cell-Based Immunotherapy Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Cell-Based Immunotherapy Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Cell-Based Immunotherapy Market Size by Country (2022-2027) & (US$ Million)
Table 62. Novartis Company Details
Table 63. Novartis Business Overview
Table 64. Novartis Cell-Based Immunotherapy Product
Table 65. Novartis Revenue in Cell-Based Immunotherapy Business (2016-2021) & (US$ Million)
Table 66. Novartis Recent Development
Table 67. Gilead Sciences Company Details
Table 68. Gilead Sciences Business Overview
Table 69. Gilead Sciences Cell-Based Immunotherapy Product
Table 70. Gilead Sciences Revenue in Cell-Based Immunotherapy Business (2016-2021) & (US$ Million)
Table 71. Gilead Sciences Recent Development
Table 72. AbbVie Company Details
Table 73. AbbVie Business Overview
Table 74. AbbVie Cell-Based Immunotherapy Product
Table 75. AbbVie Revenue in Cell-Based Immunotherapy Business (2016-2021) & (US$ Million)
Table 76. AbbVie Recent Development
Table 77. Bristol-Myers Squibb Company Details
Table 78. Bristol-Myers Squibb Business Overview
Table 79. Bristol-Myers Squibb Cell-Based Immunotherapy Product
Table 80. Bristol-Myers Squibb Revenue in Cell-Based Immunotherapy Business (2016-2021) & (US$ Million)
Table 81. Bristol-Myers Squibb Recent Development
Table 82. Amgen Company Details
Table 83. Amgen Business Overview
Table 84. Amgen Cell-Based Immunotherapy Product
Table 85. Amgen Revenue in Cell-Based Immunotherapy Business (2016-2021) & (US$ Million)
Table 86. Amgen Recent Development
Table 87. AstraZeneca Company Details
Table 88. AstraZeneca Business Overview
Table 89. AstraZeneca Cell-Based Immunotherapy Product
Table 90. AstraZeneca Revenue in Cell-Based Immunotherapy Business (2016-2021) & (US$ Million)
Table 91. AstraZeneca Recent Development
Table 92. Biogen Company Details
Table 93. Biogen Business Overview
Table 94. Biogen Cell-Based Immunotherapy Product
Table 95. Biogen Revenue in Cell-Based Immunotherapy Business (2016-2021) & (US$ Million)
Table 96. Biogen Recent Development
Table 97. Boehringer Ingelheim Company Details
Table 98. Boehringer Ingelheim Business Overview
Table 99. Boehringer Ingelheim Revenue in Cell-Based Immunotherapy Business (2016-2021) & (US$ Million)
Table 100. Boehringer Ingelheim Recent Development
Table 101. Eli Lilly and Company Company Details
Table 102. Eli Lilly and Company Business Overview
Table 103. Eli Lilly and Company Cell-Based Immunotherapy Product
Table 104. Eli Lilly and Company Revenue in Cell-Based Immunotherapy Business (2016-2021) & (US$ Million)
Table 105. Eli Lilly and Company Recent Development
Table 106. GSK Company Details
Table 107. GSK Business Overview
Table 108. GSK Cell-Based Immunotherapy Product
Table 109. GSK Revenue in Cell-Based Immunotherapy Business (2016-2021) & (US$ Million)
Table 110. GSK Recent Development
Table 111. Pfizer Company Details
Table 112. Pfizer Business Overview
Table 113. Pfizer Cell-Based Immunotherapy Product
Table 114. Pfizer Revenue in Cell-Based Immunotherapy Business (2016-2021) & (US$ Million)
Table 115. Pfizer Recent Development
Table 116. Roche Company Details
Table 117. Roche Business Overview
Table 118. Roche Cell-Based Immunotherapy Product
Table 119. Roche Revenue in Cell-Based Immunotherapy Business (2016-2021) & (US$ Million)
Table 120. Roche Recent Development
Table 121. Takara Bio Company Details
Table 122. Takara Bio Business Overview
Table 123. Takara Bio Cell-Based Immunotherapy Product
Table 124. Takara Bio Revenue in Cell-Based Immunotherapy Business (2016-2021) & (US$ Million)
Table 125. Takara Bio Recent Development
Table 126. Bausch Health Company Details
Table 127. Bausch Health Business Overview
Table 128. Bausch Health Cell-Based Immunotherapy Product
Table 129. Bausch Health Revenue in Cell-Based Immunotherapy Business (2016-2021) & (US$ Million)
Table 130. Bausch Health Recent Development
Table 131. Apac Biotech Company Details
Table 132. Apac Biotech Business Overview
Table 133. Apac Biotech Cell-Based Immunotherapy Product
Table 134. Apac Biotech Revenue in Cell-Based Immunotherapy Business (2016-2021) & (US$ Million)
Table 135. Apac Biotech Recent Development
Table 136. Dendreon Pharmaceuticals (SanPower) Company Details
Table 137. Dendreon Pharmaceuticals (SanPower) Business Overview
Table 138. Dendreon Pharmaceuticals (SanPower) Cell-Based Immunotherapy Product
Table 139. Dendreon Pharmaceuticals (SanPower) Revenue in Cell-Based Immunotherapy Business (2016-2021) & (US$ Million)
Table 140. Dendreon Pharmaceuticals (SanPower) Recent Development
Table 141. JW CreaGene Company Details
Table 142. JW CreaGene Business Overview
Table 143. JW CreaGene Cell-Based Immunotherapy Product
Table 144. JW CreaGene Revenue in Cell-Based Immunotherapy Business (2016-2021) & (US$ Million)
Table 145. JW CreaGene Recent Development
Table 146. Green Cross Corp Company Details
Table 147. Green Cross Corp Business Overview
Table 148. Green Cross Corp Cell-Based Immunotherapy Product
Table 149. Green Cross Corp Revenue in Cell-Based Immunotherapy Business (2016-2021) & (US$ Million)
Table 150. Green Cross Corp Recent Development
Table 151. Research Programs/Design for This Report
Table 152. Key Data Information from Secondary Sources
Table 153. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Cell-Based Immunotherapy Market Share by Type: 2020 VS 2027
Figure 2. Autologous Cellular Immunotherapy Features
Figure 3. Chimeric Antigen Receptor (CAR) T-Cell Therapy Features
Figure 4. Dendritic Cell-based Vaccine Therapy Features
Figure 5. Global Cell-Based Immunotherapy Market Share by Application: 2020 VS 2027
Figure 6. Hospitals Case Studies
Figure 7. Clinics Case Studies
Figure 8. Ambulatory Surgical Centers Case Studies
Figure 9. Others Case Studies
Figure 10. Cell-Based Immunotherapy Report Years Considered
Figure 11. Global Cell-Based Immunotherapy Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Cell-Based Immunotherapy Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Cell-Based Immunotherapy Market Share by Regions: 2020 VS 2027
Figure 14. Global Cell-Based Immunotherapy Market Share by Regions (2022-2027)
Figure 15. Global Cell-Based Immunotherapy Market Share by Players in 2020
Figure 16. Global Top Cell-Based Immunotherapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cell-Based Immunotherapy as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Cell-Based Immunotherapy Revenue in 2020
Figure 18. Global Cell-Based Immunotherapy Revenue Market Share by Type (2016-2021)
Figure 19. Global Cell-Based Immunotherapy Revenue Market Share by Type (2022-2027)
Figure 20. North America Cell-Based Immunotherapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Cell-Based Immunotherapy Market Share by Type (2016-2027)
Figure 22. North America Cell-Based Immunotherapy Market Share by Application (2016-2027)
Figure 23. North America Cell-Based Immunotherapy Market Share by Country (2016-2027)
Figure 24. United States Cell-Based Immunotherapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Cell-Based Immunotherapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Cell-Based Immunotherapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Cell-Based Immunotherapy Market Share by Type (2016-2027)
Figure 28. Europe Cell-Based Immunotherapy Market Share by Application (2016-2027)
Figure 29. Europe Cell-Based Immunotherapy Market Share by Country (2016-2027)
Figure 30. Germany Cell-Based Immunotherapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Cell-Based Immunotherapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Cell-Based Immunotherapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Cell-Based Immunotherapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Cell-Based Immunotherapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Cell-Based Immunotherapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Cell-Based Immunotherapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Cell-Based Immunotherapy Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Cell-Based Immunotherapy Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Cell-Based Immunotherapy Market Share by Region (2016-2027)
Figure 40. China Cell-Based Immunotherapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Cell-Based Immunotherapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Cell-Based Immunotherapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Cell-Based Immunotherapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Cell-Based Immunotherapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Cell-Based Immunotherapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Cell-Based Immunotherapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Cell-Based Immunotherapy Market Share by Type (2016-2027)
Figure 48. Latin America Cell-Based Immunotherapy Market Share by Application (2016-2027)
Figure 49. Latin America Cell-Based Immunotherapy Market Share by Country (2016-2027)
Figure 50. Mexico Cell-Based Immunotherapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Cell-Based Immunotherapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Cell-Based Immunotherapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Cell-Based Immunotherapy Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Cell-Based Immunotherapy Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Cell-Based Immunotherapy Market Share by Country (2016-2027)
Figure 56. Turkey Cell-Based Immunotherapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Cell-Based Immunotherapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Cell-Based Immunotherapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Novartis Revenue Growth Rate in Cell-Based Immunotherapy Business (2016-2021)
Figure 60. Gilead Sciences Revenue Growth Rate in Cell-Based Immunotherapy Business (2016-2021)
Figure 61. AbbVie Revenue Growth Rate in Cell-Based Immunotherapy Business (2016-2021)
Figure 62. Bristol-Myers Squibb Revenue Growth Rate in Cell-Based Immunotherapy Business (2016-2021)
Figure 63. Amgen Revenue Growth Rate in Cell-Based Immunotherapy Business (2016-2021)
Figure 64. AstraZeneca Revenue Growth Rate in Cell-Based Immunotherapy Business (2016-2021)
Figure 65. Biogen Revenue Growth Rate in Cell-Based Immunotherapy Business (2016-2021)
Figure 66. Boehringer Ingelheim Revenue Growth Rate in Cell-Based Immunotherapy Business (2016-2021)
Figure 67. Eli Lilly and Company Revenue Growth Rate in Cell-Based Immunotherapy Business (2016-2021)
Figure 68. GSK Revenue Growth Rate in Cell-Based Immunotherapy Business (2016-2021)
Figure 69. Pfizer Revenue Growth Rate in Cell-Based Immunotherapy Business (2016-2021)
Figure 70. Roche Revenue Growth Rate in Cell-Based Immunotherapy Business (2016-2021)
Figure 71. Takara Bio Revenue Growth Rate in Cell-Based Immunotherapy Business (2016-2021)
Figure 72. Bausch Health Revenue Growth Rate in Cell-Based Immunotherapy Business (2016-2021)
Figure 73. Apac Biotech Revenue Growth Rate in Cell-Based Immunotherapy Business (2016-2021)
Figure 74. Dendreon Pharmaceuticals (SanPower) Revenue Growth Rate in Cell-Based Immunotherapy Business (2016-2021)
Figure 75. JW CreaGene Revenue Growth Rate in Cell-Based Immunotherapy Business (2016-2021)
Figure 76. Green Cross Corp Revenue Growth Rate in Cell-Based Immunotherapy Business (2016-2021)
Figure 77. Bottom-up and Top-down Approaches for This Report
Figure 78. Data Triangulation
Figure 79. Key Executives Interviewed
世界の樹状細胞癌ワクチン免疫療法市場規模・現状・予測（2021年-2027年） Dendritic cells (DCs) are one of the major antigen-presenting cells found in lymphoid organs. Main function of the dendritic cells is antigen display and activation of T-cells. Antigen display presents the identity of pathogen to T-cells for their identification and elimination from the body. These …- 世界のCAR-T細胞免疫療法市場規模・現状・予測（2021年-2027年） CAR T-Cell Immunotherapy is a new type of cancer treatment. This emerging treatment represents one of the biggest breakthroughs since the introduction of chemotherapy. T cells is a type of white blood cell extracted from the patient’s blood by doctors, and added an artificial receptor to their surfa…
- 世界の自己細胞療法市場規模・現状・予測（2021年-2027年） Autologous cell therapy refers to the injection or delivery of human tissue or cells to the same person to treat pathological conditions. For the same purpose, the stem cells are taken out of the patient, harvested, cultured, and transplanted again to the same person. The purpose of this method is t…
- 世界の自家幹細胞＆非幹細胞系治療法市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market The global Autologous Stem Cell and Non-Stem Cell Based Therapies market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry…
- T細胞免疫療法のグローバル市場調査 2019年 The global T-Cell Immunotherapy market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on T-Cell Immunotherapy volume and value at global level, regional level and company level. From a global perspective, th…